H.C. Wainwright Reiterates Buy Rating on Albireo Pharma (ALBO), "We Remain Highly Confident in Bylvay's Likelihood of Success"
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce reiterated a Buy rating and $80.00 price target on Albireo Pharma (NASDAQ: ALBO), following announcement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
